Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of … – Nasdaq
|
Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of …
Nasdaq “This partnership brings together our collective experience in Duchenne drug development and Genethon’s particular expertise in gene therapy for rare diseases. We look forward to working with Genethon given their knowledge, large infrastructure and … |
|
Huntington’s Reversed with CRISPR
Anti Aging News Scientists made use of CRISPR/Cas9 gene editing delivered through a viral vector. They snipped a segment of a gene that produces toxic protein aggregates within the brains of mice. Several weeks later, the aggregated proteins nearly disappeared in the … |
Anti Aging News |
Huntington’s Reversed with CRISPR
Anti Aging News Scientists made use of CRISPR/Cas9 gene editing delivered through a viral vector. They snipped a segment of a gene that produces toxic protein aggregates within the brains of mice. Several weeks later, the aggregated proteins nearly disappeared in the … |
|
Huntington’s Reversed with CRISPR
Anti Aging News Scientists made use of CRISPR/Cas9 gene editing delivered through a viral vector. They snipped a segment of a gene that produces toxic protein aggregates within the brains of mice. Several weeks later, the aggregated proteins nearly disappeared in the … |
Scicasts (press release) (blog) |
Study Finds Distant Brain Regions Selectively Recruit Stem Cells
Scicasts (press release) (blog) Basel, Switzerland (Scicasts) — Stem cells persist in the adult mammalian brain and generate new neurons throughout life. A research group at the Biozentrum of the University of Basel reports in the current issue of “Science” that long-distance brain … |